| Literature DB >> 33533880 |
Wilson Luu1,2, Barbara Zangerl1,2, Michael Kalloniatis1,2, Stephen Palmisano3, Juno Kim1.
Abstract
Purpose: Leading causes of irreversible blindness such as age-related macular degeneration (AMD) and glaucoma can, respectively, lead to central or peripheral vision loss. The ability of sufferers to process visual motion information can be impacted even during early stages of eye disease. We used head-mounted display virtual reality as a tool to better understand how vision changes caused by eye diseases directly affect the processing of visual information critical for self-motion perception.Entities:
Year: 2021 PMID: 33533880 PMCID: PMC7862735 DOI: 10.1167/iovs.62.2.4
Source DB: PubMed Journal: Invest Ophthalmol Vis Sci ISSN: 0146-0404 Impact factor: 4.799
Characteristics of Observers
| Normal | Glaucoma | Age-Related Macular Degeneration | Total | |
|---|---|---|---|---|
| No. of participants | 16 | 19 | 17 | 52 |
| Mean Age ± SD | 66.06 ± 9.05 | 66.84 ± 6.30 | 66.41 ± 7.21 | 66.49 ± 7.32 |
| No. of females (males) | 5 (11) | 8 (11) | 10 (7) | 23 (29) |
| Mean Binocular Visual Acuity (LogMAR) ± SD | 0.08 ± 0.12 | 0.08 ± 0.08 | 0.09 ± 0.11 | 0.09 ± 0.11 |
| 55.60 ± 26.82 | 77.67 ± 45.39 | 71.25 ± 45.49 | 79.46 ± 73.64 | |
| Mean Deviation (dB) ± SD | — | — | — | |
| Right | −2.10 ± 1.58 | |||
| Left | −1.68 ± 1.58 |
SD, standard deviation.
Mean stereoacuity and standard deviation calculated in participants who could perceive global stereopsis.
Figure 1.Mean vection (top row), spatial presence (middle row), and cybersickness ratings (bottom row) plotted as function of simulated speed for each of the viewing conditions (passive radial, active radial, and active compensation) and for each eye group (normal, age-related macular degeneration, and glaucoma). Error bars: Standard error of the mean.
Figure 2.Difference plots for vection score (a and d), presence rating (b and e) and cybersickness (c and f) during passive and two active viewing conditions. Top row: Comparison between age-related macular degeneration group and healthy participants (a, b, and c). Bottom row: Comparison between glaucoma group and healthy participants (d, e, and f). Error bars: 95% CI.